Back to search

Article

<i>Babesia duncani</i> as a model organism to study the development, virulence and drug susceptibility of intraerythrocytic parasites <i>in vitro</i> and <i>in vivo</i>

2021-12-01

Abstract excerpt

Hematozoa are a subclass of protozoan parasites that invade and develop within vertebrate red blood cells to cause the pathological symptoms associated with diseases of both medical and veterinary importance such as malaria and babesiosis. A major limitation in the study of the most prominent hematozoa, Plasmodium spp, the causative agents of malaria, is the lack of a broadly accessible mouse model to evaluate pa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
fd400b01-3c96-59bb-962c-9808eb4d9a90
DOI
10.1101/2021.12.01.470698
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
<i>Babesia duncani</i> as a model organism to study the development, virulence and drug susceptibility of intraerythrocytic parasites <i>in vitro</i> and <i>in vivo</i>DOI 10.1101/2021.12.01.470698
Babesia duncani as a Model Organism to Study the Development, Virulence, and Drug Susceptibility of Intraerythrocytic Parasites In Vitro and In VivoSemantic proximity
A Propidium Iodide-based <i>In Vitro</i> Screen of the “Bug Box” Against <i>Babesia duncani</i> Reveals Potent InhibitorsSemantic proximity
Development of an Ectopic huLiver Model for <i>Plasmodium</i> Liver Stage InfectionSemantic proximity
Establishment and Optimisation of Anti-Babesia microti Drug Efficacy Evaluation MethodSemantic proximity
Why is <i>Babesia</i> not killed by artemisinin like <i>Plasmodium</i> ?Semantic proximity
Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of <i>Plasmodium falciparum</i> reveals several inhibitory compoundsSemantic proximity
Improved Murine Model of Malaria Using<i>Plasmodium falciparum</i>Competent Strains and Non-Myelodepleted NOD-<i>scid IL2R</i>γ<sup><i>null</i></sup>Mice Engrafted with Human ErythrocytesSemantic proximity
Establishment and application of unbiased <i>in vitro</i> drug screening assays for the identification of compounds against <i>Echinococcus granulosus s.s</i>Semantic proximity
Host porphobilinogen deaminase deficiency confers malaria resistance in <i>Plasmodium chabaudi</i> but not in <i>Plasmodium berghei</i> or <i>Plasmodium falciparum</i> during intraerythrocytic growthSemantic proximity
A new <i>in vitro</i> checkerboard-parasite reduction ratio interaction assay for early de-risk of clinical development of antimalarial combinationsSemantic proximity
Screening of a chemogenetic library unveils dual-stage antimalarials with low cytotoxicitySemantic proximity
Exploring the Potential of Malvidin and Echiodinin as Probable Antileishmanial Agents Through <i>In Silico</i> Analysis And <i>In Vitro</i> EfficacySemantic proximity
Select a neighboring publication to make it the new centre.